Skip to content

CORT

Corcept Therapeutics Incorporated

Revenue to net income

Key figures

MetricLast 12 months5-year CAGR
Revenue$964M+16.6%
Gross profit$950M+16.5%
Operating income$111M−19.0%
Net income$162M−1.2%
EPS$1.27−0.7%
Free cash flow$195M−1.2%